Trial Profile
A retrospective study of patients previously treated for Atrial fibrillation to compare different QT interval measurements.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Sep 2015
Price :
$35
*
At a glance
- Drugs Dofetilide (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 14 Sep 2015 New trial record